A searchable database of
medically documented cases

About the Project

Spontaneous Regression Of Chronic Lymphocytic Leukemia To A Monoclonal B-lymphocytosis Or To A Normal Phenotype

Nakhla et al., 2013Leukemia

Nakhla, P. S., Butera, J. N., Treaba, D. O., Castillo, J. J., & Quesenberry, P. J. (2013). spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype. Leukemia & lymphoma, 54(8), 1647–1651. https://doi.org/10.3109/10428194.2012.753449

View Original Source →

Abstract

Spontaneous remission of chronic lymphocytic leukemia (CLL) is an unusual and poorly characterized event. We performed a search for spontaneous remission in patients with CLL. Cases must have had a pathological diagnosis of CLL with disease duration > 6 months. Spontaneous remission was defined as absence of lymphadenopathy or splenomegaly with lymphocyte counts < 5 × 10(9)/L for > 9 months without therapy. We identified 20 cases and included one additional case from our institution. Fourteen cases (67%) showed remission into monoclonal B lymphocytosis (MBL) and seven (33%) into a normal phenotype. There was no difference in age distribution, lymphocyte count or stage between groups. There was a significant difference in the median duration of CLL prior to remission, 13 years in the MBL versus 3 years in the normal phenotype group (p = 0.03). This difference in the duration of CLL prior to remission could be due to a possible distinct pathophysiology for these events.

Case Details

Disease Location

Blood

Personal Characteristics

70-year-old man

Clinical Characteristics

Routine laboratory analysis to have a white blood cell count (wbc) of 21 x10^9/l with 81% lymphocytes. His initial flow cytometry showed 69% of the lymphoid cells examined were kappa light chain restricted CD19+/CD20+ b-lymphoid cells the patient was classified as rai stage 0 cll. In april 2009, the patient suffered a myocardial infarction. The patient underwent cardiac catheterization during which he developed an acute immune-related thrombocytopenia due to epatientifibatide, which required platelet transfusions

Remission Characteristics

On his next hematologic follow-up, 5 months later, he was noted to have a normal wbc of 5.6 x10^9/l and a normal lymphocyte number of 2.6 x10^9/l.

Treatment & Mechanisms

Proposed Remission Mechanisms

Not discussed

Clinical Treatment

Cardiac catheterization epatientifibatide platelet transfusions